title: FK 506 treatment of intractable rejection after liver transplantation.
authors.affiliation: Klinik für Abdominal- und Transplantationschirurgie, Hannover, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Jost
authors.forename: M
authors.initials: M
authors.lastname: Winkler
authors.forename: B
authors.initials: B
authors.lastname: Ringe
authors.forename: B
authors.initials: B
authors.lastname: Rodeck
authors.forename: R
authors.initials: R
authors.lastname: Pichlmayr
mesh_terms: D000208:Acute Disease; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008297:Male; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*
chemical_list: D016572:Cyclosporine; D003404:Creatinine; D000410:Alanine Transaminase; D001663:Bilirubin; D016559:Tacrolimus